NCT02038777 2025-02-26
A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies
Pfizer
Phase 1 Completed
Clinical Trials
7 trialsNCT00953758 2024-04-25
A Study Of PF-04449913 In Select Hematologic Malignancies
Pfizer
Phase 1 Completed
NCT01286467 2024-03-06
A Study Of PF-04449913 Administered Alone In Select Solid Tumors
Pfizer
Phase 1 Completed
NCT04842604 2023-12-18
Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
Pfizer
Phase 3 Completed
NCT04230564 2023-06-07
Acute Myeloid Leukemia Real World Treatment Patterns
Pfizer
Withdrawn
NCT03416179 2023-04-21
BRIGHT AML1019
Pfizer
Phase 3 Completed
NCT01546038 2020-03-03
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Pfizer
Phase 2 Completed